These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12550744)
21. Prospects for gene therapy in inherited neurodegenerative diseases. Cardone M Curr Opin Neurol; 2007 Apr; 20(2):151-8. PubMed ID: 17351484 [TBL] [Abstract][Full Text] [Related]
22. Gene medicine : a new field of molecular medicine. Kim CK; Haider KH; Lim SJ Arch Pharm Res; 2001 Feb; 24(1):1-15. PubMed ID: 11235805 [TBL] [Abstract][Full Text] [Related]
23. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection. Smythe JA; Symonds G Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023 [No Abstract] [Full Text] [Related]
24. The biochemistry of gene therapy for AIDS. Savarino A; Pescarmona GP; Turco E; Gupta P Clin Chem Lab Med; 1998 Apr; 36(4):205-10. PubMed ID: 9638344 [TBL] [Abstract][Full Text] [Related]
25. RNA-based gene therapy for HIV infection. Dorman N; Lever AM HIV Med; 2001 Apr; 2(2):114-22. PubMed ID: 11737388 [No Abstract] [Full Text] [Related]
26. Non-viral gene therapy: Gains and challenges of non-invasive administration methods. Foldvari M; Chen DW; Nafissi N; Calderon D; Narsineni L; Rafiee A J Control Release; 2016 Oct; 240():165-190. PubMed ID: 26686079 [TBL] [Abstract][Full Text] [Related]
27. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system. Zlokovic BV; Apuzzo ML Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in the pharmacology of neurological gene therapy. Lowenstein PR; Castro MG Curr Opin Pharmacol; 2004 Feb; 4(1):91-7. PubMed ID: 15018845 [TBL] [Abstract][Full Text] [Related]
29. [Gene therapy for human hearing loss: challenges and promises]. Meyer A; Petit C; Safieddine S Med Sci (Paris); 2013 Oct; 29(10):883-9. PubMed ID: 24148127 [TBL] [Abstract][Full Text] [Related]
30. Non-viral vectors in cancer gene therapy: principles and progress. Schatzlein AG Anticancer Drugs; 2001 Apr; 12(4):275-304. PubMed ID: 11335785 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects. Giannoukakis N; Trucco M Biotechniques; 2003 Jul; 35(1):122-45. PubMed ID: 12866413 [TBL] [Abstract][Full Text] [Related]
36. Editorial: Current Gene Therapy on Non-viral Gene Delivery and Therapy. Peng L Curr Gene Ther; 2018; 18(1):2. PubMed ID: 29769001 [No Abstract] [Full Text] [Related]
37. Regulated protein expression for in vivo gene therapy for neurological disorders: progress, strategies, and issues. Manfredsson FP; Bloom DC; Mandel RJ Neurobiol Dis; 2012 Nov; 48(2):212-21. PubMed ID: 22426391 [TBL] [Abstract][Full Text] [Related]
38. Stacking up CRISPR against RNAi for therapeutic gene inhibition. Haussecker D FEBS J; 2016 Sep; 283(17):3249-60. PubMed ID: 27090508 [TBL] [Abstract][Full Text] [Related]
39. The challenge of gene therapy and DNA delivery. Phillips AJ J Pharm Pharmacol; 2001 Sep; 53(9):1169-74. PubMed ID: 11578098 [TBL] [Abstract][Full Text] [Related]